Epithelial-mesenchymal transition(EMT)Àº Á¤»óÀû ¹è¾Æ¹ß´Þ °úÁ¤¿¡¼ ¹ß»ýÇÏ´Â Çö»óÀ¸·Î, ¼¼Æ÷°¡ »óÇÇ(epithelial)¼º ¼¼Æ÷ Ç¥ÇöÇüÀ» »ó½ÇÇϰí À̵¿¼ºÀÌ ³ôÀº Áß°£¿±(mesenchymal)¼º ¼¼Æ÷ Ç¥ÇöÇüÀ¸·Î ÀüȯÇÏ´Â °úÁ¤¿¡¼ ºñ°¡¿ªÀûÀ¸·ÎÁøÇàµÉ °æ¿ì ½ÉÀå, °£, ½ÅÀå ¹× Ç÷°ü ±â´É ºÎÀüÀ» ÃÊ·¡ÇÒ »Ó ¾Æ´Ï¶ó ¾Ç¼º Á¾¾çÀÇ ÀüÀÌ¿¡µµ °ü¿©ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. º» ¿¬±¸È¸´Â ÀÌ·¯ÇÑ EMT ±âÃÊ¿ø¸® ¹× Ư¼ºÀ» ÀÌÇØÇÔÀ¸·Î½á ÁÖ¿ä Àå±â ¼¶À¯ÈÁõ°ú ÀÌÇ༺ Á¾¾ç°ú °°Àº ³Ä¡¼º ÁúȯÀÇ ¿¹¹æ, Áø´Ü ¹× Ä¡·á ü°è¸¦ ¿¬±¸Çϰí Åä·ÐÇÏ´Â ¸ðÀÓÀÔ´Ï´Ù. µû¶ó¼ º» ½ÉÆ÷Áö¿ò¿¡¼´Â ÃÖ±Ù¿¡ »õ·Ó°Ô µîÀåÇϰí ÀÖ´Â ½Ã½ºÅÛ »ý¹°ÇÐÀ» ÀÌ¿ëÇÑ EMT Á¦¾î±â¼ú È®¸³ÀÇ ±Ù°£À» ¸¶·ÃÇϰíÀÚ ´ë³»¿ÜÀûÀ¸·Î EMT °ü·Ã ¿¬±¸µ¿Çâ ¹× ¿¬±¸ÀÚ°£ÀÇ ¿¬±¸¹ßÀü ¹æÇâÀ» Á¦½ÃÇÏ´Â ±íÀÌ ÀÖ´Â Åä·ÐÀÇ ÀåÀ» ¸¶·ÃÇϰíÀÚ ÇÕ´Ï´Ù.
ÀÌâȣ ±³¼ö (ÇѾç´ëÇб³ Àǰú´ëÇÐ) |
 |
|
"Overview on the epithelial-mesenchymal transition in terms of targeting of
phosphoinositide signaling" |
 |
¹Ú¼®Èñ ±³¼ö (¼º±Õ°ü´ëÇб³ ÀÚ¿¬°úÇдëÇÐ) |
 |
|
"EMT and TGF-β signaling" |
 |
ÀÌÀçÈ£ ±³¼ö (¾ÆÁÖ´ëÇб³ Àǰú´ëÇÐ) |
 |
|
"Epithelial-mesenchymal transition of hepatocytes through
TGF-β contributes to liver fibrosis" |
 |
±è»ó°Ç ±³¼ö (¼¿ï´ëÇб³ ¾àÇдëÇÐ) |
 |
|
"Gα12/Gα13 regulation
of TGFβ1-dependent liver fibrosis" |
 |
ÇÑ»ó¿í ±³¼ö (¾ÆÁÖ´ëÇб³ Àǰú´ëÇÐ) |
 |
|
"Loss of the Smad3 expression increases
susceptibility to tumorigenicity in human gastric cancer" |
 |
±è´ë°ï ±³¼ö (ÀüºÏ´ëÇб³ Àǰú´ëÇÐ) |
 |
|
"ANAXA8 downregulation by FOXO4
phosphorylation involves tumor cell metastasis" |
 |
Á¶±¤Çö ±³¼ö (¼¿ï´ëÇб³ Àǰú´ëÇÐ) |
 |
|
"Introduction to systems biology: Perspectives and challenges" |
 |
ÃÖ»óµ· ±³¼ö (¾ÆÁÖ´ëÇб³ ºÐÀÚ±â¼úÇаú) |
 |
|
"A system biological approach of EMT: Lessons
from Alliance for Cellular Signaling" |